Botanical derivatives for the prostate.
The prostate, after the age of 45 years, may undergo benign hyperplasia (BPH). Its etiology has not yet been completely explained, but different factors play a major role in its occurrence, among them, the sexual hormones (with a fundamental role of 5 alpha reductase). The 5-alpha reductase activity and inflammatory aspects in the prostate tissue can be effectively controlled with the use of highly standardized plant extracts (Pygeum africanum, Serenoa repens, etc.), which yield excellent results in the prophylaxis and treatment of the symptoms linked to prostate hypertrophy. The prostate tissue is not affected only by benign diseases but may also be subject to neoplastic transformation. From an epidemiological point of view, a vegetable derivative, lycopene, was linked with a lower occurrence of prostate carcinoma. A recent clinical study demonstrated that lycopene might not only prevent prostate cancer but also have therapeutic effects.
Scientific Department, Indena S.p.A., Viale Ortles 12, 20139, Milan, Italy. indenami@tin.it
A
A
Cristoni
F
F
Di Pierro
E
E
Bombardelli
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D002338:Carotenoids / Q000627:therapeutic use; D006801:Humans; D000077276:Lycopene; D008297:Male; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D000068218:Prunus africana; D051381:Rats; D028024:Serenoa
D000972:Antineoplastic Agents, Phytogenic; D010936:Plant Extracts; D002338:Carotenoids; D000077276:Lycopene